explore -WSS

explore

author：hotspot 2025-09-29 22:50:55 - browse：95218

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Ed Silverman on new gene therapies, biosimilars, coffee, and more

Wikipedia

WSS

SEC charges former device maker CEO with $41 million fraud

In Spain, a hospital brews its own CAR

Medicare inequities exacerbate Puerto Rico’s health disparities

Dario to buy mental health app maker Twill in cash and stock deal

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Drinking less cuts risk of oral cavity, esophageal cancer: Report

explore

explore

leisure time

DIEP, the 'gold standard' of breast reconstruction, is under threat

A solution to the after

The cancer drug shortage isn’t new — and neither are the solutions

Dario to buy mental health app maker Twill in cash and stock deal

Guidelines to prevent youth baseball injuries need more muscle

New documents shed light on MD Anderson Cancer Institute feud

Hepatitis C has a cure — but many Americans still lack access to it

A solution to the after

Heart attack and stroke risk calculators need revising

SNAP should offer more nutrition education

Wikipedia

What STAT readers think about the FDA and patient advocacy

A new nitrogen execution bill also undermines medical licensing

David Ricks of Eli Lilly: best biopharma CEO of 2023

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Antivenom research: Lessons from HIV applied in search for universal antidote

Wikipedia

Wikipedia

focus

focus